Sermorelin

Growth Hormone / IGF-1 Axis
Discontinued
FDA Approved
Component of FDA Drug

Sermorelin is a synthetic 29-amino-acid growth hormone-releasing compound. It was FDA-approved for pediatric growth hormone deficiency and is widely used off-label for anti-aging and body composition improvement.

Last updated February 22, 2026
35 PubMed-Verified Studies
Very Popular
Research-Driven Dosage Reports
RouteSubcutaneous (SC)
Dose200–500 mcg
Frequency1× daily (before bed)
Duration3–6 months

Based on published research literature.

Verified sources for Sermorelin

These vendors are vetted by PeptideWiki for purity testing and COA transparency.

SwissChems10% off
View all vendor deals·Affiliate links. Commission at no extra cost.

Overview of Sermorelin

Stimulates natural pulsatile growth hormone release from the pituitary while preserving physiological feedback mechanisms.

Growth hormone axis

Binds to GHRH receptors on pituitary somatotroph cells, triggering cAMP-mediated signaling cascades.

Stimulates natural pulsatile release of growth hormone, preserving physiological secretion patterns and negative feedback.

Increases hepatic IGF-1 production, mediating anabolic effects on muscle, bone, and connective tissue.

Physiological preservation

Maintains hypothalamic-pituitary axis feedback (unlike exogenous HGH), reducing risk of pituitary suppression.

Short half-life (~10-20 minutes) requires bedtime administration, augmenting the natural nocturnal GH surge

Read Full Sermorelin Dosage Guide

Research-backed dosing protocols, timing, and administration details

Browse more in this category

Growth Hormone / IGF-1 Axis